George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBarr (A.G.) Regulatory News (BAG)

Share Price Information for Barr (A.G.) (BAG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 566.00
Bid: 562.00
Ask: 565.00
Change: 2.00 (0.35%)
Spread: 3.00 (0.534%)
Open: 563.00
High: 572.00
Low: 559.00
Prev. Close: 564.00
BAG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading update for the 26 weeks ended 30 July 2023

1 Aug 2023 07:00

RNS Number : 8079H
Barr(A.G.) PLC
01 August 2023
 

IMMEDIATE RELEASE 1 August 2023

A.G. BARR p.l.c.

("A.G. BARR" or "the Group")

 

Strong first half performance

A.G. BARR p.l.c., a branded multi-beverage business with a portfolio of market-leading UK brands, including IRN-BRU, Rubicon, FUNKIN and Boost, today announces a trading update for the 26 weeks ended 30 July 2023.

Revenue for the first half of the financial year is expected to be c.£210m (2022/3 : £157.9m). This represents c.33% year-on-year revenue growth - c.10% on a like-for-like basis - excluding the contribution from the Boost Drinks business acquired in December 2022.

The Group delivered revenue and volume growth, reflecting underlying brand momentum, the benefit of higher pricing from early in the year and particularly good weather in June :

● Barr Soft Drinks and Boost Drinks - strong trading performance across the soft drinksdivisions driven by volume growth, pricing and mix, alongside effective sales execution and successful consumer marketing activity

● FUNKIN Cocktails - revenue growth driven by further distribution gains, increased consumer marketing investment and continued exciting innovation, particularly in the retail channel. While cocktail consumption in the on-trade has slowed following last year's post-Covid high, FUNKIN has maintained its position as the UK's Number 1 cocktail brand

● MOMA Foods - brand and consumer marketing investment supporting significant year on year growth, as oat milk outperforms other plant-based milk categories

As anticipated, first half margins remained under pressure but are in line with our expectations. We remain focused on offering consumers great value, affordable brands.

H2 outlook

We exit the first half with strong brand momentum. The Scottish deposit return scheme delay provides us with a more stable and certain consumer environment and enables the accelerated execution of our innovation plans. We now have a number of exciting brand launches planned for the second half of the year.

We continue to progress our strategic brand investment programme at pace across the Group. As previously stated, the current full year Group operating margin will be impacted by persistent cost inflation alongside the known near-term impact of the lower margin Boost division.

We currently expect our full year profit performance to be marginally above the top end of analyst expectations.

Roger White, Chief Executive, commented:

"In March we communicated that 2023/24 would be a year of investment across the business, supporting the Group's long-term revenue and profit growth ambitions. I am pleased to report we have had a strong first half, despite ongoing macro cost challenges. Our focus remains on offering consumers great value, affordable brands. 

Our medium-term plan to rebuild the Group's operating profit margin is progressing well across a range of activities, including supply chain optimisation, cost management and portfolio development. We have strong brand plans in place across the business for the balance of the year to sustain our growth momentum and we remain confident in the Group's long-term growth strategy".

For more information, please contact :

A.G. BARR Instinctif Partners

0330 390 3900 020 7457 2010/05

Roger White, Chief Executive Justine Warren

Stuart Lorimer, Finance Director Matthew Smallwood

Next update : Interim Results - 26 September 2023

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFIDDDILVIV
Date   Source Headline
23rd Apr 20249:17 amRNSAnnual Financial Report
15th Apr 20242:59 pmRNSDirector/PDMR Shareholding
9th Apr 20243:46 pmRNSDirector/PDMR Shareholding - replacement
9th Apr 20243:36 pmRNSDirector/PDMR Shareholding
9th Apr 20241:05 pmRNSDirector/PDMR Shareholding - replacement
9th Apr 202412:50 pmRNSDirector/PDMR Shareholding
5th Apr 20242:26 pmRNSDirector/PDMR Shareholding
2nd Apr 202411:15 amRNSDirector/PDMR Shareholding
28th Mar 202410:10 amRNSDirector/PDMR Shareholding
26th Mar 20247:00 amRNSDirectorate changes announcement
26th Mar 20247:00 amRNSFinal Results
14th Mar 20243:01 pmRNSBusiness reorganisation
11th Mar 20248:39 amRNSDirector/PDMR Shareholding
27th Feb 20241:47 pmRNSHolding(s) in Company
8th Feb 20242:03 pmRNSDirector/PDMR Shareholding - Replacement
8th Feb 20241:51 pmRNSDirector/PDMR Shareholding
1st Feb 20247:00 amRNSBoard succession announcement
1st Feb 20247:00 amRNSTrading Update
16th Jan 20247:00 amRNSNotice of Trading Update
9th Jan 20241:36 pmRNSDirector/PDMR Shareholding
14th Dec 20239:22 amRNSDirector Declaration
11th Dec 20239:47 amRNSDirector/PDMR Shareholding
17th Nov 202310:13 amRNSUpdate statement on 2023 AGM Voting Results
8th Nov 202310:45 amRNSDirector/PDMR Shareholding
3rd Nov 20233:44 pmRNSDirector/PDMR Shareholding
30th Oct 20233:10 pmRNSDirector/PDMR Shareholding
24th Oct 20237:00 amRNSAcquisition of tropical drinks brand Rio
10th Oct 20238:21 amRNSDirector/PDMR Shareholding
26th Sep 20237:00 amRNSInterim Results
11th Sep 20239:08 amRNSDirector/PDMR Shareholding
8th Aug 20232:07 pmRNSDirector/PDMR Shareholding
1st Aug 20237:00 amRNSBoard succession announcement
1st Aug 20237:00 amRNSTrading update for the 26 weeks ended 30 July 2023
10th Jul 202312:42 pmRNSDirector/PDMR Shareholding
14th Jun 20239:40 amRNSDirector/PDMR Shareholding
13th Jun 20239:24 amRNSDirector/PDMR Shareholding - Replacement
13th Jun 20238:59 amRNSDirector/PDMR Shareholding
13th Jun 20238:55 amRNSDirector/PDMR Shareholding
12th Jun 20233:59 pmRNSDirector/PDMR Shareholding
8th Jun 20231:02 pmRNSDirector/PDMR Shareholding
26th May 20231:57 pmRNSDirectorate Change
26th May 20231:55 pmRNSResult of AGM
10th May 20239:25 amRNSDirector/PDMR Shareholding
4th May 20239:22 amRNSDirector Declaration
25th Apr 20239:14 amRNSAnnual Financial Report / Notice of AGM
12th Apr 20233:31 pmRNSDirector/PDMR Shareholding
12th Apr 202311:23 amRNSDirector/PDMR Shareholding
11th Apr 202310:07 amRNSDirector/PDMR Shareholding
30th Mar 202310:24 amRNSDirector/PDMR Shareholding
28th Mar 20237:00 amRNSBoard succession update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.